This inventor holds 1 USPTO granted patent. Top assignee: The State University of New York. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: The Innovative Contributions of Steven J Kasper
Introduction
Steven J Kasper is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel polynucleotide analogs. His work has implications for cancer treatment and therapeutic applications.
Latest Patents
Kasper holds a patent for "Novel polynucleotide analogs, methods for inhibiting nucleic acid." This patent describes polyribonucleotide analogs that are partially substituted by the introduction of mercapto groups and fluorine at the 5-position of some of their cytosine and uracil bases. These analogs exhibit effective in vivo antitumor activity. The double-stranded complexes formed from such polynucleotides are especially active as interferon inducers. He has 1 patent to his name.
Career Highlights
Kasper is affiliated with The State University of New York, where he continues to engage in research and innovation. His work has contributed to advancements in molecular biology and therapeutic strategies.
Collaborations
He has collaborated with notable colleagues, including Yau-Kwan Ho and Robert G Hughes, Jr. These partnerships have enhanced the scope and impact of his research.
Conclusion
Steven J Kasper's innovative work in the field of biotechnology exemplifies the potential of polynucleotide analogs in cancer treatment. His contributions continue to influence research and development in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile